DIFFERENT HLA DR-DQ ASSOCIATIONS IN SUBGROUPS OF IDIOPATHIC MYASTHENIA-GRAVIS

被引:64
|
作者
CARLSSON, B
WALLIN, J
PIRSKANEN, R
MATELL, G
SMITH, CIE
机构
[1] SODER SJUKHUSET, DEPT NEUROL, CTR MYASTHENIA GRAVIS, STOCKHOLM, SWEDEN
[2] KAROLINSKA INST, HUDDINGE UNIV HOSP, NOVUM, DEPT CLIN IMMUNOL, S-14152 HUDDINGE, SWEDEN
关键词
D O I
10.1007/BF02115001
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
We have investigated the HLA-DRB and -DQB gene polymorphism in 131 myasthenia gravis (MG) patients. The HLA genotypes in these patients were assigned by means of restriction fragment length polymorphism (RFLP)-defined DR-DQ haplotypes, correlating to serologic HLA class II typing. Using this technique we could, among randomly selected non-thymomatous (NT)-MG patients, confirm the strong association to DR3, and 70% of the patients were found to carry a specific DR3-positive DR-DQ haplotype, T-3.1. Furthermore, an analysis of T-3.1- NT-MG patients revealed that 59 % were T-4.1÷ (DR4, DQw8). Thymic hyperplasia was found in approximately 85 % of the T-3.1+, as well as of the T-4.1+ /3.1- patients. As previously observed, we found a clear dominance of females among the T-3.1+ NT-MG patients. However, among T-4.1+/3.1- patients, males were as common as females. Furthermore, the T-4.1+ patients were significantly older at the onset of disease than those who were T-3.1+. In female MG patients, the DRwl5-Dw2-positive haplotype T-2.1 was strongly correlated with the presence of thymoma (T-MG). These data indicate that the HLA associations in early vs late onset of NT-MG are different, and that female patients with and without thymoma differ from each other with regard to HLA markers. Thus, at least three different HLA DR-DQ associations are found in subgroups of idiopathic MG. © 1990 Springer-Verlag.
引用
收藏
页码:285 / 290
页数:6
相关论文
共 50 条
  • [1] ANALYSIS OF HLA DR AND DQ BETA-GENES IN MYASTHENIA-GRAVIS PATIENTS
    SMITH, CIE
    CARLSSON, B
    HAMMARSTROM, L
    MATELL, G
    MOLLER, E
    PIRSKANEN, R
    WALLIN, J
    ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1987, 505 : 816 - 819
  • [2] MYASTHENIA-GRAVIS PATIENTS WITH THYMUS HYPERPLASIA AND MYASTHENIA-GRAVIS PATIENTS WITH THYMOMA DISPLAY DIFFERENT HLA ASSOCIATIONS
    SPURKLAND, A
    GILHUS, NE
    RONNINGEN, KS
    AARLI, JA
    VARTDAL, F
    TISSUE ANTIGENS, 1991, 37 (02): : 90 - 93
  • [3] HLA-DETERMINED SUBGROUPS OF MYASTHENIA-GRAVIS
    GROSS, WL
    SCHLAAK, M
    KLINISCHE WOCHENSCHRIFT, 1977, 55 (08): : 405 - 405
  • [4] IMMUNE DISEASE AND HLA ASSOCIATIONS WITH MYASTHENIA-GRAVIS
    BEHAN, PO
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1980, 43 (07): : 611 - 621
  • [5] SUBGROUPS OF MYASTHENIA-GRAVIS
    SCHERBAUM, WA
    SCHUMM, F
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1983, 108 (31-3) : 1218 - 1218
  • [6] HLA-DQ RESTRICTION FRAGMENT LENGTH POLYMORPHISMS IN MYASTHENIA-GRAVIS
    BELL, JI
    STEINMAN, L
    TOYKA, K
    MCDEVITT, HO
    ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1987, 505 : 382 - 387
  • [7] ASSOCIATION OF HLA-DR4 WITH MYASTHENIA-GRAVIS IN THE CHINESE
    LEE, TD
    ZHAO, TM
    BU, KJ
    LU, CZ
    ODONNELL, M
    SANDLER, SG
    TISSUE ANTIGENS, 1984, 23 (02): : 127 - 129
  • [8] HLA SYSTEM AND MYASTHENIA-GRAVIS
    SAARI, KM
    ACTA OPHTHALMOLOGICA, 1984, : 92 - 95
  • [9] HLA ANTIGENS IN MYASTHENIA-GRAVIS
    AMITAI, Y
    ZAMIR, R
    KOTT, E
    ISRAEL JOURNAL OF MEDICAL SCIENCES, 1979, 15 (10): : 872 - 873
  • [10] HLA-DQ BETA-CHAIN POLYMORPHISM LINKED TO MYASTHENIA-GRAVIS
    BELL, J
    SMOOT, S
    NEWBY, C
    TOYKA, K
    RASSENTI, L
    SMITH, K
    HOHLFELD, R
    MCDEVITT, H
    STEINMAN, L
    LANCET, 1986, 1 (8489): : 1058 - 1060